Which patients are at greatest risk for premature death following discharge? ©Lightspring/Shutterstock
Related content:Promising New Option for Treatment of Tardive Dyskinesia
Therapy for Cognition: Restoring the Self in Bipolar Disorder
Functional remediation therapy addresses the cognitive problems of the nearly 50% of patients who remain impaired even when euthymic.
Marijuana and the Psychiatric Patient
Marijuana-related problems fall well within the scope of psychiatric practice: many patients use marijuana, which is likely to affect their psychiatric symptoms and response to treatment.
Mortality Risk After Discharge From Psychiatric Care
Which patients are at greatest risk for premature death following discharge?
Promising New Option for Treatment of Tardive Dyskinesia
The results of a phase 3 trial demonstrated significant benefit over placebo.
Putting a Face on Serious Mental Illness
In recent years, violence has unfortunately become the tragic touchstone that too often draws the public’s attention to mental illness.
How About a Game of Chess?
A psychiatrist's chess game with his patient didn't go the way he expected.
Julia and the Little Shoots
The therapist "goes underwater" with the patient to find what lies in her mind.
Marijuana—Legal, But Not by Prescription
What are the pros and cons of marijuana use? Dr Andrew Saxon gives his viewpoint on why he is against medical marijuana but in favor of legalization of recreational use of marijuana.
New Psychopharmacology Algorithms
Dr David Osser offers compelling reasons why you might want to take a look at these 7 algorithms, each of which offers actionable consultations—usually in under 2 minutes.
New Research in the Genetics of Autism
An expert discusses the clinical, biological, and genetic components of de novo mutations and autism spectrum disorders.
Impaired Glucose Homeostasis in First-Episode Schizophrenia
Recent findings suggest metabolic abnormalities may be independent of the effects of antipsychotics.
How Best to Make the Switch to Clozapine
What’s the optimal approach for patients with treatment-resistant schizophrenia?
Ultrahigh-Risk Psychosis: Do Things Come in (Omega)-3s?
Can dietary supplementation decrease the risk of transition to psychosis?
Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.
By clicking Accept, you agree to become a member of the UBM Medica Community.